期刊文献+

自制电化学发光检测N末端B型利钠肽原室内质控品及应用评价 被引量:3

The comparison and evaluation of the self-developed control products and the internal quality control products detection of NT-proBNP by electrochemiluminescence
下载PDF
导出
摘要 目的探讨制备电化学发光检测N末端B型利钠肽原(NT-proBNP)室内质控品的方法。方法收集NT-proBNP检测结果较高的冠心病患者血清及NT-proBNP正常者血清,分为低值组和高值组。进行预期靶值及批内重复精度测定、批内天间不精密度测定、稳定性试验,并与罗氏公司原厂质控品比较,评估自制室内质控品与原厂质控品检测结果的偏倚是否在可接受范围内。结果自制NT-proBNP质控品日内重复性和稳定性良好、不精密度符合临床检测标准,在控范围明显小于罗氏公司提供的质控允许范围,可满足室内质控要求。结论自制NT-proBNP室内质控品可以替代进口原配质控品。 Objective To investigate the preparation of internal quality control products of NT-proBNP by electrochemiluminescence detection.Methods The serum with high and normal levels of NT-proBNP were collected and divided into low-value group and high-value group.The expected target value,inter-batch duplicability,imprecision and the stability within batch were detected.After effective verification,we evaluated the bias between self developed internal quality control products and Roche factory quality control materials by comparative test.Results The repeatability,stability and imprecision of self developed NT-proBNP were all appropriate to internal quality control products and meeting meet the clinical testing standards.The control range was significantly less than that permitted by Roche,so it can meet the internal quality control requirements.Conclusion The self developed NTproBNP internal quality control products can replace the imports quality control products.
出处 《国际检验医学杂志》 CAS 2016年第19期2718-2719,2722,共3页 International Journal of Laboratory Medicine
关键词 N末端B型利钠肽原 室内质控品 检测 NT-proBNP internal quality control products detection
  • 相关文献

参考文献3

二级参考文献20

  • 1孔立新,张道杰,孙黎,卢兆莲,王雪萍.凝血检验室内质控血浆的制备与评估[J].临床检验杂志,2006,24(2):146-147. 被引量:31
  • 2黎卓华,李鄂,王希平,叶丽燕,何桂兰.自制类风湿因子质控品的应用及其质量的监控作用评价[J].国际检验医学杂志,2007,28(9):860-860. 被引量:8
  • 3Emdin M, Passino C, Prontera C, et al. Comparison of brain natriuretic peptide (BNP)and amino-terminal proBNP for early diagnosis of heart failure [ J ]. Clin Chem, 2007, 53 ( 7 ) : 1289-1297.
  • 4Green SM, Redmond P, Januzzi JL, et al. The impact of amino- terminal pro-brainnatriuretic peptide testing on hospital length of stay and morbidity in patients with acute decompensated heart failure[ J]. Arch Pathol Lab Med ,2007,131 ( 3 ) :473-476.
  • 5Kim JY, Lee EY, Jee JH, et al. N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction [ J ]. Diabetes Res Clin Pract, 2007, 77 ( 3 ) : $238-$242.
  • 6Ltithje L, Vollmann D, Drescher T, et al. Intrathoracic impedance monitoring to detect chronic heart failure deterioration : relationship to changes in NT-proBNP [ J ]. Eur J Heart Fail, 2007,9 ( 6-7 ) : 716 -722.
  • 7Schou M, Gustafsson F, Corell P, et al. The relationship between N- terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure [J]. Am Heart J,2007,154( 1 ) :123-129.
  • 8Fonseca C, Sarmento PM, Minez A, et al. Comparative value t / BNP and NTproBNP in diagnosis of heart failure [ J ]. Rev PoI / Cardiol, 2004,23 ( 7-8 ) : 979 -991.
  • 9Doust JA, Pietrzak E, Dobson A, et al. How well does B-type natnuretic peptide predict death and cardiac events in patients with heart failure : systematic review [ J ]. BMJ,2005,330 (7492) :625.
  • 10Yeo KT, Wu AH, Apple FS, et al. Muhicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay[ J]. Clin Chim Acta,2003,338 (1-2) : 107-115.

共引文献11

同被引文献21

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部